Blood bank reagents and analyzers, fort benning, georgia

Ended Definitive Contract Awarded Last action

Contract number
W91YTZ20C0030
Awardee
Awarding agency
Obligated
$835,630

Award facts

Contract value 100% obligated
$835,630.06 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
Set-aside
No set-aside
Competition
2 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Fort Benning, GA 31905, USA

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Funding Only Action P00013 · Blood bank reagents -$1,644
Funding Only Action P00012 · KMW umod reagents mach $166,519
Exercise an Option P00011 · FY25 OPT MOD $0
Funding Only Action P00010 · MOD fund FY24 $166,519
Exercise an Option P00009 · Blood bank reagents $0
Funding Only Action P00008 · MOD fund FY23 $166,519
Funding Only Action P00007 · MOD fund FY22 $12,701
Exercise an Option P00006 · MOD - OPT 2 SAF FY23 W91YTZ20C0030 PR 11782839 $0
Other Administrative Action P00005 · FY22 ROF W91YTZ20C0030 PR 11641402-00001 $166,519
Exercise an Option P00004 · FY22 SAF-option year i--W91YTZ20C0030 $0
Other Administrative Action P00003 · Administrative MOD to remove clause 52.229-12 $0
Supplemental Agreement for work within scope P00002 · Increase modification W91YTZ20C0030 -$8,020
Funding Only Action P00001 · Blood bank reagents-martin army community hospital-ROF FY21 modification to add funding. $166,519
Original award $0
Show all 14

About this award

The Defense Health Agency awarded a firm fixed-price, definitive contract valued at $835,630.06 to Immucor Inc. on October 1, 2020, to supply blood bank reagents, analyzers, and related services to Martin Army Community Hospital at Fort Moore, Georgia. The contract runs through September 30, 2025, with an ultimate completion date aligned to the base period and four optional one-year extensions. Immucor, a Norcross, Georgia-based manufacturer of in vitro diagnostic products and blood transfusion compatibility testing equipment, will furnish two NEO automated blood bank analyzers, installation services, preventative maintenance, removal services, and comprehensive reagent supplies to support an estimated annual workload exceeding 300,000 tests. The contractor is required to complete validation and correlation studies within 45 days of award and have equipment operational by October 1, 2020. No set-aside designation was applied to this procurement.

This award reflects the Defense Health Agency's commitment to equipping military medical facilities with specialized diagnostic capabilities for blood banking operations and transfusion medicine. Immucor has established itself as a key supplier to federal healthcare agencies, holding multiple Indefinite Delivery/Indefinite Quantity agreements and Blanket Purchase Agreements with the Defense Health Agency and other military commands. The blood bank analyzer and reagent supply contract supports critical compatibility testing, ABO/Rh typing, antibody screening, and identification procedures required to maintain safe blood transfusion operations across the Department of the Army Medical Command network.

Quick answers

Who was awarded contract W91YTZ20C0030?

W91YTZ20C0030 was awarded to Immucor Inc. by Medical Command (Department of the Army) on October 1, 2020.

How much is contract W91YTZ20C0030 worth?

The government has obligated $835,630 on W91YTZ20C0030.

Which agency awarded contract W91YTZ20C0030?

Medical Command (Department of the Army) awarded W91YTZ20C0030, with funding from Defense Health Agency (Department of Defense).

Was contract W91YTZ20C0030 competed?

The government received 2 offers.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award